As part of the settlement agreement, CVS will pay Texas $276 million, adding to the $2.37 billion the state has already received from drug distributors.
In an agreement that would make it the first major pharmacy chain to reach a nationwide settlement of lawsuits over how it handled prescriptions for powerful and addictive prescription opioid painkillers, CVS would pay about $5 billion over 10 years. Other pharmacies, including Rite Aid, Walgreens and Walmart have reached agreements with individual states.
In the lawsuits, governments said pharmacies were filling prescriptions that they should have flagged as inappropriate. Opioids have been linked to more than 500,000 deaths in the U.S. over the past two decades. Most of the deaths initially involved prescription drugs. As governments, doctors and companies took steps to make them harder to abuse and obtain, people with opioid use disorder increasingly switched to heroin, which proved more deadly.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Howie Mandel defends Meghan Markle's Deal Or No Deal commentsDeal Or No Deal host Howie Mandel has no problem with Meghan Markle's confession she felt objectified on the game show
Weiterlesen »
Like FDR’s New Deal, Biden’s tax-and-spend policies have been an economic wrecking ballThe economic gaslighting coming out of Washington is astounding, even by D.C. standards.
Weiterlesen »
US says it won't ‘waste time’ on Iran nuclear dealThe U.S. envoy to Iran said Monday that the Biden administration will not 'waste time' on reviving Iran's 2015 nuclear deal amid Tehran's crackdown on protesters and its support of Russia.
Weiterlesen »
After Roquan Smith Traded by Bears, Here's Who Ryan Poles Could Deal NextThe Bears traded Roquan Smith to the Ravens, according to Ian Rapoport and Adam Schefter, in exchange for a second-round pick and a fifth-round pick in next year’s draft.
Weiterlesen »
J&J’s heart deal pumps up post-breakup prospectsThe healthcare firm will get a measly return in the near term from paying $16.6 bln for heart-pump maker Abiomed. But J&J is buying growth: Abiomed’s 20% revenue growth can probably continue for several years. That provides ballast as J&J prepares to spin off its consumer arm.
Weiterlesen »
Russia agrees to continue with Ankara-brokered grain deal - ErdoganRussia had announced on Saturday that it would suspend its participation in the UN-brokered Black Sea grain export deal due to Ukrainian attacks on its Black Sea Fleet's ships.
Weiterlesen »